Analyte |
Result and interpretation |
|
ADA |
≥40 IU/L |
Suggestive of tuberculosis |
Albumin, [S] – [P] |
≥11 g/L |
Portal hypertension, cirrhosis, alcoholic hepatitis, multiple metastases to the liver, heart failure |
<11 g/L |
Peritoneal metastases, tuberculosis, pancreatitis, serositis, nephrotic syndrome |
|
Protein, total |
<10 g/L |
Increased risk of spontaneous bacterial peritonitis in cirrhosis |
≥10 g/L |
Peritonitis secondary to esophageal perforation |
|
Glucose, [P]/[S] |
<1.0 |
WBCs, bacteria, and neoplastic cells in the fluid; glucose levels may be indeterminable in esophageal perforation |
LDH, [P]/[S] |
~0.4 |
Ascites without complications in cirrhosis |
>1.0 |
Infection, malignancy |
|
Amylase, [P]/[S] |
>1.0 |
Pancreatic diseases, ~6.0 in esophageal perforation, ~0.4 in ascites without complications in cirrhosis |
Bilirubin, [P]/[S] |
>1.0 |
Bile duct perforation |
Triglycerides |
>2.26 mmol/L (200 mg/dL) |
Chyloperitoneum, often >11 mmol/L (1000 mg/dL) |
ADA, adenosine deaminase; [P]/[S], concentration in the peritoneal fluid divided by serum concentration; [S] – [P], serum concentration minus concentration in the peritoneal fluid; WBC, white blood cell. |